June 10 (Bloomberg) –- In today’s “Global Outlook,” BioDelivery Sciences CEO Mark Sirgo discusses the company's drug Bunavail, which is used to treat opioid depenedence. He speaks with Trish Regan on Bloomberg Television's "Street Smart." (Source: Bloomberg)
This text has been automatically generated. It may not be 100% accurate.